“COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities” (2016) Journal of Cancer Research Updates, 5(2), pp.  45–46. doi:10.6000/1929-2279.2016.05.02.1.